Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  Check Out View Cart

Country Report

Medicated Skin Care in

Dermatologicals in Switzerland

20 pages, Feb 2019

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

In 2018, dermatologicals registered only a marginal value increase, on the back of weakened consumer demand, which was apparent throughout the review period. The low demand is attributable to category maturity and saturation.

Low price of mass market products attracts consumers

An influx of low-cost, mass market products with a medicinal character such as antidandruff shampoos and antibacterial soaps and lotions to treat acne and mild skin conditions is attracting consumers. Consumers especially trust mass market products that contain ingredients that are supported by scientific studies, as these are considered effective; examples are retinols to clear and treat problem skin and to treat acne and peptides that reduce skin inflammation.

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

In the forecast period, value sales growth is expected to remain low in dermatologicals as market dynamics seen in the review period are expected to remain unchanged. Above all, new and innovative products that are able to reverse the slow growth are likely to be few and far between as the strict OTC legislation in the country will remain in place.

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

In 2018, the top five players were multinationals or large European companies. Their dominance remained unchanged throughout the review period, thanks to their leading and well-known brands.

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Ranking second, Galderma Schweiz, a Nestlé subsidiary, further strengthened its position in 2018. Through Galderma, Nestlé is expanding and strengthening its interests in dermatologicals.

Fragmentation in the rest of the competitive landscape

A significant number of small to medium-sized domestic and European companies are also present in dermatologicals in Switzerland. The majority target only a narrow area in the category with one or two products.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Medicated Skin Care Market Sample Report Medicated Skin Care Market Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Switzerland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Switzerland, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Switzerland market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Medicated Skin Care in Switzerland?
What are the major brands in Switzerland?
What are the most popular formats for acne treatments?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Dermatologicals in Switzerland - Category analysis

HEADLINES

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2013-2018
Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018
Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018
Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018
Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Consumer Health in Switzerland - Industry Overview

EXECUTIVE SUMMARY

Demand drops for consumer health, leading to a weaker performance

High costs force consumers to find ways to save

Leading brands maintain their top positions

Online retailing is hit by stringent legislation

Consumer health set to see slightly positive improvement over the forecast period

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018
Table 9 Life Expectancy at Birth 2013-2018

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2013-2018
Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018
Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018
Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018
Table 15 Distribution of Consumer Health by Format: % Value 2013-2018
Table 16 Distribution of Consumer Health by Format and Category: % Value 2018
Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Megatrends

Country Report

Dermatologicals in Switzerland

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Dermatologicals in Switzerland - Category analysis

HEADLINES

PROSPECTS

Dermatologicals loses momentum as it suffers from a drop in consumer demand

Low price of mass market products attracts consumers

Lack of innovation, competition from mass market products with medicinal properties and cosmeceuticals reduce prospects for dermatologicals

COMPETITIVE LANDSCAPE

Multinationals and large European players continue to lead dermatologicals in 2018, with Bayer at their head

Nestlé subsidiary Galderma Schweiz follows Bayer in highly competitive landscape

Fragmentation in the rest of the competitive landscape

CATEGORY DATA

Consumer Health in Switzerland - Industry Overview

EXECUTIVE SUMMARY

Demand drops for consumer health, leading to a weaker performance

High costs force consumers to find ways to save

Leading brands maintain their top positions

Online retailing is hit by stringent legislation

Consumer health set to see slightly positive improvement over the forecast period

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports